These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 29100804)
21. Ubiquilin immunoreactivity in cytoplasmic and nuclear inclusions in synucleinopathies, polyglutamine diseases and intranuclear inclusion body disease. Mori F; Tanji K; Odagiri S; Toyoshima Y; Yoshida M; Ikeda T; Sasaki H; Kakita A; Takahashi H; Wakabayashi K Acta Neuropathol; 2012 Jul; 124(1):149-51. PubMed ID: 22661321 [No Abstract] [Full Text] [Related]
22. Identification of phlebovirus and arenavirus RNA sequences that stall and repress the exoribonuclease XRN1. Charley PA; Wilusz CJ; Wilusz J J Biol Chem; 2018 Jan; 293(1):285-295. PubMed ID: 29118186 [TBL] [Abstract][Full Text] [Related]
23. Nature of the nuclear inclusions formed by PQBP1, a protein linked to neurodegenerative polyglutamine diseases. Nicolaescu E; Beullens M; Lesage B; Keppens S; Himpens B; Bollen M Eur J Cell Biol; 2008 Oct; 87(10):817-29. PubMed ID: 18599155 [TBL] [Abstract][Full Text] [Related]
24. DIS3L2 and LSm proteins are involved in the surveillance of Sm ring-deficient snRNAs. Roithová A; Feketová Z; Vaňáčová Š; Staněk D Nucleic Acids Res; 2020 Jun; 48(11):6184-6197. PubMed ID: 32374871 [TBL] [Abstract][Full Text] [Related]
25. mRNA decay is regulated via sequestration of the conserved 5'-3' exoribonuclease Xrn1 at eisosome in yeast. Vaškovičová K; Awadová T; Veselá P; Balážová M; Opekarová M; Malinsky J Eur J Cell Biol; 2017 Sep; 96(6):591-599. PubMed ID: 28501103 [TBL] [Abstract][Full Text] [Related]
27. Polyglutamine aggregation in Huntington's disease and spinocerebellar ataxia type 3: similar mechanisms in aggregate formation. Seidel K; Siswanto S; Fredrich M; Bouzrou M; Brunt ER; van Leeuwen FW; Kampinga HH; Korf HW; Rüb U; den Dunnen WF Neuropathol Appl Neurobiol; 2016 Feb; 42(2):153-66. PubMed ID: 26095752 [TBL] [Abstract][Full Text] [Related]
28. Spatio-temporal characterization of the antiviral activity of the XRN1-DCP1/2 aggregation against cytoplasmic RNA viruses to prevent cell death. Ng CS; Kasumba DM; Fujita T; Luo H Cell Death Differ; 2020 Aug; 27(8):2363-2382. PubMed ID: 32034313 [TBL] [Abstract][Full Text] [Related]
29. Characterization of a TUTase/RNase complex required for Lin CJ; Wen J; Bejarano F; Hu F; Bortolamiol-Becet D; Kan L; Sanfilippo P; Kondo S; Lai EC RNA; 2017 Mar; 23(3):284-296. PubMed ID: 27974621 [TBL] [Abstract][Full Text] [Related]
31. Activation of 5'-3' exoribonuclease Xrn1 by cofactor Dcs1 is essential for mitochondrial function in yeast. Sinturel F; Bréchemier-Baey D; Kiledjian M; Condon C; Bénard L Proc Natl Acad Sci U S A; 2012 May; 109(21):8264-9. PubMed ID: 22570495 [TBL] [Abstract][Full Text] [Related]
32. Nanoparticle-induced cell culture models for degenerative protein aggregation diseases. Chen M; von Mikecz A Inhal Toxicol; 2009 Jul; 21 Suppl 1():110-4. PubMed ID: 19558242 [TBL] [Abstract][Full Text] [Related]
33. Regulation of Hepatitis C Virus Genome Replication by Xrn1 and MicroRNA-122 Binding to Individual Sites in the 5' Untranslated Region. Thibault PA; Huys A; Amador-Cañizares Y; Gailius JE; Pinel DE; Wilson JA J Virol; 2015 Jun; 89(12):6294-311. PubMed ID: 25855736 [TBL] [Abstract][Full Text] [Related]
34. SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease. Pountney DL; Huang Y; Burns RJ; Haan E; Thompson PD; Blumbergs PC; Gai WP Exp Neurol; 2003 Nov; 184(1):436-46. PubMed ID: 14637113 [TBL] [Abstract][Full Text] [Related]
35. A noncoding RNA produced by arthropod-borne flaviviruses inhibits the cellular exoribonuclease XRN1 and alters host mRNA stability. Moon SL; Anderson JR; Kumagai Y; Wilusz CJ; Akira S; Khromykh AA; Wilusz J RNA; 2012 Nov; 18(11):2029-40. PubMed ID: 23006624 [TBL] [Abstract][Full Text] [Related]
36. Sigma-1 receptor is involved in degradation of intranuclear inclusions in a cellular model of Huntington's disease. Miki Y; Tanji K; Mori F; Wakabayashi K Neurobiol Dis; 2015 Feb; 74():25-31. PubMed ID: 25449906 [TBL] [Abstract][Full Text] [Related]
37. Transcriptional repression and cell death induced by nuclear aggregates of non-polyglutamine protein. Fu L; Gao YS; Sztul E Neurobiol Dis; 2005 Dec; 20(3):656-65. PubMed ID: 15964198 [TBL] [Abstract][Full Text] [Related]
38. Abnormalities of the nucleus and nuclear inclusions in neurodegenerative disease: a work in progress. Woulfe JM Neuropathol Appl Neurobiol; 2007 Feb; 33(1):2-42. PubMed ID: 17239006 [TBL] [Abstract][Full Text] [Related]
39. Differential effects of polyglutamine proteins on nuclear organization and artificial reporter splicing. Sun J; Xu H; Negi S; Subramony SH; Hebert MD J Neurosci Res; 2007 Aug; 85(11):2306-17. PubMed ID: 17526020 [TBL] [Abstract][Full Text] [Related]
40. Regionally different immunoreactivity for Smurf2 and pSmad2/3 in TDP-43-positive inclusions of amyotrophic lateral sclerosis. Nakamura M; Kaneko S; Wate R; Asayama S; Nakamura Y; Fujita K; Ito H; Kusaka H Neuropathol Appl Neurobiol; 2013 Feb; 39(2):144-56. PubMed ID: 22435645 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]